Dogwood Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Dogwood Therapeutics, Inc. (DWTX) had Operating Lease, Weighted Average Discount Rate, Percent of 7.82% as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 7.82%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 7.82%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.82%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 7.82%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 7.82% 10-Q · filed 2026-08-14 |
| 2026-03-31 | 7.82% 10-Q · filed 2026-05-15 |
| 2025-12-31 | 7.82% 10-K · filed 2026-03-18 |
| 2025-09-30 | 7.82% 10-Q · filed 2025-11-07 |
| 2025-06-30 | 7.82% 10-Q · filed 2026-08-14 |
| 2025-03-31 | 7.82% 10-Q · filed 2025-05-09 |
| 2024-12-31 | 7.82% 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |